Nutraceuticals for the control of dyslipidaemias in clinical practice

HIGHLIGHTS

  • who: Peter E. Penson and Maciej Banach from the School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool , TX, UK have published the research: Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice, in the Journal: Nutrients 2021, 13, 2957. of 25/08/2021
  • what: The development of nutraceuticals from the micronutrient components of food presents an opportunity to target dyslipidaemias and atherosclerosis through direct effects on plasma lipids, and through the modification of pathophysiological processes elicited through atherogenic lipoproteins.

SUMMARY

    The recent draft recommendations to European . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?